Literature DB >> 13190212

Primidone in mental deficiency practice.

D S SHARPE.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/therapeutic use; EPILEPSY/therapy; MENTAL DEFICIENCY/complications

Mesh:

Substances:

Year:  1954        PMID: 13190212      PMCID: PMC2078923          DOI: 10.1136/bmj.2.4888.627

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Treatment of epilepsy with mysoline.

Authors:  L GREENSTEIN; M R SAPIRSTEIN
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-10

2.  Value of primidone in epilepsy.

Authors:  C W WHITTY
Journal:  Br Med J       Date:  1953-09-05

3.  Mysoline in the treatment of epilepsy.

Authors:  A J M BUTTER
Journal:  Lancet       Date:  1953-05-23       Impact factor: 79.321

4.  Mysoline; a new drug in the treatment of epilepsy.

Authors:  R HANDLEY; A S STEWART
Journal:  Lancet       Date:  1952-04-12       Impact factor: 79.321

  4 in total
  2 in total

1.  DISCUSSION on recent advances in treatment.

Authors: 
Journal:  Proc R Soc Med       Date:  1956-08

Review 2.  Primidone Intolerance in Essential tremor: Is it More than Just Age?

Authors:  Abhishek Lenka; Elan D Louis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.